Skip to main
AFL

Aflac (AFL) Stock Forecast & Price Target

Aflac (AFL) Analyst Ratings

Based on 13 analyst ratings
Hold
Strong Buy 0%
Buy 15%
Hold 54%
Sell 31%
Strong Sell 0%

Bulls say

Aflac is facing short-term challenges in Japan due to above target benefit ratios, weaker currency movements, and lower sales. However, the company has a strong product portfolio, including new offerings such as accident, dental and vision, disability, and long-term-care insurance, which are expected to drive future growth. The company also has a solid plan for cross-selling between its different segments and expects to exceed previous sales numbers in the future. While external reinsurance transactions have had a negative impact on earnings in the short term, the company expects this to normalize over time, and the benefit ratio for the Japan segment is expected to remain within the previously stated range.

Bears say

Aflac is facing challenges with its acquisition strategy and restructuring efforts, as seen in the recent large restructuring of the investment income portfolio and a plan to increase ceding of Japanese liabilities. Additionally, the quarter result was weaker than expected due to high Japanese benefit ratio and slower premium revenues. In order to achieve flat or positive in-force period-over-period on an annual basis, the company will need to significantly increase its sales, with a target of at least JPY 80 billion.

Aflac (AFL) has been analyzed by 13 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 15% recommend Buy, 54% suggest Holding, 31% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aflac and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aflac (AFL) Forecast

Analysts have given Aflac (AFL) a Hold based on their latest research and market trends.

According to 13 analysts, Aflac (AFL) has a Hold consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $116.92, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $116.92, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aflac (AFL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.